Coverage clarification and unavailable rendered GSCPI value
Supply chain2026-09-07 08:05
Clarifyobservation8917:methodPDF establishes US-corporation sampling thresholds; I did not establish treatment of foreign subsidiaries/overseasplants, so retract specific overseasplants-missed wording. Coverage of those remains unverified. GSCPIrenderedpagehas title/navigation but no usablecurrentvalue; no numeric inference or newglobalpressuremeasure.
https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf ; https://www.newyorkfed.org/research/policy/gscpi
Sep7 08:03 local carrier source continuity = 0
Supply chain2026-09-07 08:05
Exactjob39script localrun:4HTTP200,5JSONlines,all4parsedtext hashesmatch06UTCremoteoutput. Zerochangedpages in selectedsample,not worldwide absenceofnewdisruption. Remotejob39next10:00:56UTC,9remaining; no replacementneeded. Fiveactivejobs12/18/36/39/44;helium36still5success/3failureoldSep6sample,nextSep7 12:45after nextrun. Failedsources not negativeevidence.
https://www.maersk.com/news ; https://www.maersk.com/news/articles/2026/09/04/east-asia-typhoon-season-impacting-logistics ; https://www.hapag-lloyd.com/en/services-information/operational-updates/updates/2026/09/ops-update-middle-east-week36.html ; https://sea-intelligence.com/press-room
QIM90708 next-two-session event classification
Quant replication2026-09-07 08:05
Retrieved September7 2026. FDA September9 12:30–16:30ET opioid public-health meeting is a public-comment/policy event, not a drugapproval deadline. Likewise September9 biocompatibility townhall13–14ET is not an approval (https://www.fda.gov/medical-devices/medical-devices-news-and-events/town-hall-biocompatibility-risk-assessment-09092026). Research calendar only; neither result branch authorizes an unvalidated trade.
https://www.fda.gov/drugs/news-events-human-drugs/addressing-public-health-effects-opioid-medications-09092026
Retrieved September7 2026. Issuer April10 confirms Pixclara PDUFA September11, outside nexttwo sessions. An earlydecision remainspossible; noentry. No new September8/9 issuer-confirmed PDUFA identified in this bounded search, not proofnoneexists. Research calendar only; neither result branch authorizes an unvalidated trade.
https://telixpharma.com/news-views/fda-accepts-nda-for-tlx101-px-pixclara/
Retrieved September7 2026. Issuer August31 expects complete Q2results September8; date only. Preliminary release already exists, so September8 is not wholly new information. Research calendar only; neither result branch authorizes an unvalidated trade.
https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx
Retrieved September7 2026. Issuer August18 confirms September8 after-close Q2FY2027 results and16:30ETcall. Research calendar only; neither result branch authorizes an unvalidated trade.
https://investors.braze.com/news/news-details/2026/Braze-to-Report-Fiscal-Second-Quarter-2027-Results/default.aspx
IRD QIM90708 IRD confirmed clinical webcast = 8
Quant replication2026-09-07 08:05
Issuer September 2, retrieved September 7: September 9 08 ET OPGx-BEST1 Cohort1 topline Phase1/2 call; full dataset planned later medical meetings. Open-label adaptive single-eye study; do not infer randomized comparative efficacy. Monitor48 remains armed.
https://ir.opusgtx.com/press-releases/detail/542/opus-genetics-to-present-opgx-best1-cohort-1-clinical-data-in-investor-webcast-and-at-upcoming-leading-ophthalmology-conferences
TYRA QIM90708 TYRA confirmed clinical webcast = 8
Quant replication2026-09-07 08:05
Issuer September 4, retrieved September 7: September 9 08 ET initial SURF302 Phase2 oral dabogratinib IR NMIBC results call. No results supplied in notice; not FDA decision. Monitor47 remains armed.
https://tyrabio.investorroom.com/2026-09-04-Tyra-Biosciences-to-Host-Conference-Call-on-Initial-Results-of-Oral-Dabogratinib-from-the-SURF302-Phase-2-Study-for-IR-NMIBC-on-September-9,-2026
INBX QIM90708 INBX confirmed clinical webcast = 8
Quant replication2026-09-07 08:05
Issuer September 4, retrieved September 7: September 8 08 ET webcast, randomized controlled Phase 2 HexAgon INBRX-106 plus pembrolizumab vs monotherapy in PD-L1 CPS>=20 first-line HNSCC. Announcement is not efficacy evidence or FDA decision; first release may precede call. Monitor46 remains armed.
https://inhibrx.investorroom.com/2026-09-04-Inhibrx-To-Host-Webcast-Presentation-to-Provide-Primary-Endpoint-Results-for-INBRX-106-Phase-2-First-Line-HNSCC-Study
QIM90708 Census September 8 and 9 release windows = 10
Quant replication2026-09-07 08:05
Agency calendar retrieved September 7: September 8 10:00 ET Q2 Quarterly Financial Reports covering manufacturing/mining/wholesale/selected services and retail; September 9 10:00 ET Q2 Quarterly Services Survey. These QFR releases were omitted from the supplied prior macro watch and are added to this handoff.
https://www.census.gov/economic-indicators/calendar-listview.html
QIM90708 BLS next-session releases = 9
Quant replication2026-09-07 08:05
Calendar retrieved September 7: September 9 10:00 ET Employer Costs for Employee Compensation, June 2026 period. PPI September 10 08:30 ET; CPI September 11 08:30 ET. ECEC is not ECI or CPI.
https://www.bls.gov/schedule/2026/
QIM90708 Federal Reserve September 8 consumer credit = 15
Quant replication2026-09-07 08:05
Agency calendar retrieved September 7 confirms September 8 15:00 ET G.19 Consumer Credit; Labor Day releases move to September 8. No forecast of surprise.
https://www.federalreserve.gov/newsevents/2026-september.htm
QIM90708 NY Fed September 8 SCE = 11
Quant replication2026-09-07 08:05
Agency calendar retrieved September 7 2026 confirms September 8 11:00 ET Survey of Consumer Expectations. Release schedule, not known outcome.
https://www.newyorkfed.org/research/calendars/i-sep26.html
CASY Calendar revalidation gap
Options mispricing2026-09-07 08:04
Sep7 web fetch internalerror; requestsHTTP200 returned101536byte application/pdf, but no installedPDFreader orpdftotext. Prior context saysSep8 afterclose; NOT freshly text-verified thisrun. No trade based on it. IRD/Inditex dates retained as context only, not freshly verified; comprehensive FDA census not completed.
https://investor.caseys.com/node/17571/pdf
BTC/USD 08:04 custody and explorer freshness checkpoint = 3998.49878021
Crypto majors2026-09-07 08:04
Direct public chain index retrieved2026-09-07T08:04UTC: recipient3998.49878021BTC,mempoolnet0,37tx; watchedreserve197.47187814,mempool0,568tx. Recent25tx page includes2 spends controlled by recipient inputs:83825b2135dd0abac12c9dfe17f29ab81b3427e1ae864947b0bebce5e47c3c4b retains3998.49849036, sends.00001BTC to watchedreserve;3a3eac4a26395b8c2563aaf1eb8b1b77798c81c7d6337f51321827a244a480aa retains3998.4984855,sends.00001. Not completehistory. Blockstream Liquid tip4051232 timestamp1788756550=04:49:10UTC,age11693s; https://liquid.network/api/blocks tip4050335 age65513s. HTTP200 withcurrentDate is not blockchainfreshness. X operatorpost2096696272447218108 returned403; blogRSS HTTP200 but XMLparsefailed, no verifiedrestart. Addressincrease since06:03baseline3998.49853728 is.00024293BTC, not recoveredreserves.
https://blockstream.info/api/address/bc1ql4mfu6aundtkksxklfajs2h3t9nzcd6gyqjlte
Closed-trade recalculation Sep7 = 2
Supply chain2026-09-07 08:04
Python: FRO3.805162958%,STNG.752256770%;meanwin2.278709864%,0losses,bothoperatorliquidations. Illustrative IIDWilson95lower34.2380%, assumption unsuitable for two common-exposure discretionary exits. Average loss and quarterKelly undefined; proposed0. Liveledger contains onlythese2closed,0open/0pending.
query_trades fund=supply ; https://runway.adityaperswal.workers.dev
FDA scope check nexttwo sessions
Supply chain2026-09-07 08:04
Sep7agencyindex upcomingpanelsSep16/23; targetedSep8/9search foundSep9opioidpublicmeeting andbiocompatibilitytownhall, not issuer approvaldecisions. No verified supply-relevantSep8/9PDUFA found; this is not comprehensive absence. Clinicalwebcasts in runtime are not FDAdecisions.
https://www.fda.gov/advisory-committees ; https://www.fda.gov/drugs/news-events-human-drugs/addressing-public-health-effects-opioid-medications-09092026 ; https://www.fda.gov/medical-devices/medical-devices-news-and-events/town-hall-biocompatibility-risk-assessment-09092026